Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.
Thomas Raphael MeinelMattia BrancaGian Marco De MarchisKrassen NedeltchevTimo KahlesLeo BonatiMarcel ArnoldMirjam Rachel HeldnerSimon JungEmmanuel CarreraElisabeth DirrenPatrik MichelDavide StramboCarlo Walter CeredaGiovanni BiancoGeorg KägiJochen VehoffMira KatanManuel BologneseRoland BackhausStephan SalmenSylvan AlbertFriedrich MedlinChristian BergerLudwig ScheloskySusanne RenaudJulien NiederhauserChristophe BonvinMichael SchaererMarie-Luise MonoBiljana RodicAlexander A TarnutzerPasquale MordasiniJan GrallaJohannes KaesmacherStefan EngelterUrs FischerDavid Julian Seiffgenull nullPublished in: Annals of neurology (2020)
Prior DOAC therapy in patients with AF was associated with decreased admission stroke severity at onset and a remarkably low rate of IVT. Overall, patients on DOAC might have better functional outcome at 3 months. Further research is needed to overcome potential restrictions for IVT in patients taking DOACs. ANN NEUROL 2021;89:42-53.
Keyphrases
- atrial fibrillation
- direct oral anticoagulants
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- emergency department
- venous thromboembolism
- stem cells
- left atrial
- oral anticoagulants
- catheter ablation
- climate change
- blood brain barrier
- patient reported outcomes
- left ventricular
- bone marrow